Company Filing History:
Years Active: 2015-2016
Title: Innovations in Diabetes Treatment by Daniel J Moore
Introduction
Daniel J Moore is an accomplished inventor based in Nashville, TN (US), known for his significant contributions to diabetes research. He holds two patents that focus on innovative methods for preserving insulin-producing cells and enhancing insulin production.
Latest Patents
Moore's latest patents involve compositions for preserving insulin-producing cells and treating diabetes through Nuclear Transport Modifiers such as cSN50 and cSN50.1. These inventions have shown promising results in vivo, providing islet protection in autoimmune diabetes-prone, non-obese diabetic (NOD) mice. Remarkably, his research resulted in a diabetes-free state for one year without apparent toxicity or the need for insulin. The cSN50 compound significantly reduces the accumulation of islet-destructive autoreactive lymphocytes while promoting the death of T and B lymphocytes derived from NOD mice. Additionally, cSN50 has been shown to attenuate pro-inflammatory cytokine and chemokine production in immune cells, providing cytoprotection of beta cells and preserving residual insulin-producing capacity. This innovative approach may also be applicable in treating Type 2 diabetes (T2D) by lowering fasting blood glucose levels and reducing insulin resistance.
Career Highlights
Moore is affiliated with Vanderbilt University, where he continues to advance his research in diabetes treatment. His work has garnered attention for its potential to transform the management of diabetes, a condition affecting millions worldwide.
Collaborations
Moore collaborates with esteemed colleagues such as Jack Jacek Hawiger and Jozef Zienkiewicz, contributing to a robust research environment focused on innovative solutions for diabetes.
Conclusion
Daniel J Moore's innovative work in diabetes treatment exemplifies the potential of scientific research to improve health outcomes. His patents represent a significant step forward in the fight against diabetes, showcasing the importance of continued innovation in this critical field.